Logo image of MTRX

MATRIX SERVICE CO (MTRX) Stock Fundamental Analysis

NASDAQ:MTRX - Nasdaq - US5768531056 - Common Stock - Currency: USD

13.08  -0.95 (-6.77%)

After market: 13.08 0 (0%)

Fundamental Rating

3

MTRX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 49 industry peers in the Construction & Engineering industry. MTRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MTRX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MTRX had negative earnings in the past year.
In the past year MTRX had a positive cash flow from operations.
MTRX had negative earnings in each of the past 5 years.
In multiple years MTRX reported negative operating cash flow during the last 5 years.
MTRX Yearly Net Income VS EBIT VS OCF VS FCFMTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.56%, MTRX is doing worse than 84.78% of the companies in the same industry.
With a Return On Equity value of -22.19%, MTRX is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.56%
ROE -22.19%
ROIC N/A
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
MTRX Yearly ROA, ROE, ROICMTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Gross Margin of MTRX (5.19%) is worse than 80.43% of its industry peers.
In the last couple of years the Gross Margin of MTRX has declined.
MTRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
MTRX Yearly Profit, Operating, Gross MarginsMTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

5

2. Health

2.1 Basic Checks

MTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MTRX has more shares outstanding than it did 1 year ago.
MTRX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MTRX Yearly Shares OutstandingMTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MTRX Yearly Total Debt VS Total AssetsMTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MTRX has an Altman-Z score of 1.85. This is not the best score and indicates that MTRX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.85, MTRX is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
MTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.85
ROIC/WACCN/A
WACC10.2%
MTRX Yearly LT Debt VS Equity VS FCFMTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.01 indicates that MTRX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.01, MTRX is doing worse than 78.26% of the companies in the same industry.
A Quick Ratio of 0.99 indicates that MTRX may have some problems paying its short term obligations.
MTRX has a worse Quick ratio (0.99) than 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.99
MTRX Yearly Current Assets VS Current LiabilitesMTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

MTRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.58%.
The Revenue has decreased by -7.48% in the past year.
MTRX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.46% yearly.
EPS 1Y (TTM)-44.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-7.48%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%6.93%

3.2 Future

Based on estimates for the next years, MTRX will show a very strong growth in Earnings Per Share. The EPS will grow by 74.17% on average per year.
Based on estimates for the next years, MTRX will show a quite strong growth in Revenue. The Revenue will grow by 18.50% on average per year.
EPS Next Y74.84%
EPS Next 2Y74.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.33%
Revenue Next 2Y18.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MTRX Yearly Revenue VS EstimatesMTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B
MTRX Yearly EPS VS EstimatesMTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

MTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MTRX is valuated reasonably with a Price/Forward Earnings ratio of 11.94.
Based on the Price/Forward Earnings ratio, MTRX is valued cheaper than 91.30% of the companies in the same industry.
MTRX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11.94
MTRX Price Earnings VS Forward Price EarningsMTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MTRX indicates a rather cheap valuation: MTRX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA N/A
MTRX Per share dataMTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

MTRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTRX's earnings are expected to grow with 74.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.17%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MATRIX SERVICE CO

NASDAQ:MTRX (2/21/2025, 8:00:01 PM)

After market: 13.08 0 (0%)

13.08

-0.95 (-6.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners83.75%
Inst Owner Change-2.5%
Ins Owners4.3%
Ins Owner Change7.96%
Market Cap361.14M
Analysts82.86
Price Target18.36 (40.37%)
Short Float %1.36%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.62%
Min EPS beat(2)-1.42%
Max EPS beat(2)12.66%
EPS beat(4)2
Avg EPS beat(4)-65.41%
Min EPS beat(4)-307.54%
Max EPS beat(4)34.64%
EPS beat(8)3
Avg EPS beat(8)-61.36%
EPS beat(12)4
Avg EPS beat(12)-91.09%
EPS beat(16)4
Avg EPS beat(16)-355.18%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)-0.89%
Revenue beat(4)0
Avg Revenue beat(4)-7.54%
Min Revenue beat(4)-16.66%
Max Revenue beat(4)-0.89%
Revenue beat(8)0
Avg Revenue beat(8)-7.13%
Revenue beat(12)3
Avg Revenue beat(12)-4.28%
Revenue beat(16)3
Avg Revenue beat(16)-5.66%
PT rev (1m)-5.56%
PT rev (3m)0%
EPS NQ rev (1m)-133.67%
EPS NQ rev (3m)-115.78%
EPS NY rev (1m)-669.12%
EPS NY rev (3m)-669.12%
Revenue NQ rev (1m)-15.95%
Revenue NQ rev (3m)-11.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.94
P/S 0.51
P/FCF 3.33
P/OCF 3.08
P/B 2.38
P/tB 2.96
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)1.1
Fwd EY8.38%
FCF(TTM)3.92
FCFY30.01%
OCF(TTM)4.25
OCFY32.5%
SpS25.65
BVpS5.5
TBVpS4.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -22.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.19%
FCFM 15.3%
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
F-Score4
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 86.85%
Cap/Sales 1.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.99
Altman-Z 1.85
F-Score4
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)50.41%
Cap/Depr(5y)54.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y74.84%
EPS Next 2Y74.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.48%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%6.93%
Revenue Next Year23.33%
Revenue Next 2Y18.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.7%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y222.03%
FCF growth 3YN/A
FCF growth 5Y24.61%
OCF growth 1Y241.09%
OCF growth 3YN/A
OCF growth 5Y11.89%